Dinani apa ngati iyi ndi nkhani yanu yosindikiza!

Mankhwala a Losartan High Blood Pressure Tsopano Akukumbukiridwa

Written by mkonzi

Mint Pharmaceuticals Inc. ikukumbukira mapiritsi ake ambiri a losartan, mu mphamvu za 50 mg ndi 100 mg, atayesedwa atapeza zonyansa za azido (5-(4′-((5-(azidomethyl)-2-butyl-4-chloro) -1H imidazol-1-yl) methyl)-[1,1′-biphenyl]-2-yl) -1H tetrazole) pamwamba pa malire ovomerezeka. Kuwonekera kwa nthawi yayitali ku zonyansa zomwe zili pamwamba pa zomwe zimaonedwa kuti ndizotetezeka kungathe kuonjezera chiopsezo cha khansa.

Sangalalani, PDF ndi Imelo

Chonde onani upangiri wonse kuti mumve zambiri, kuphatikiza zomwe anthu aku Canada ayenera kuchita ndi ntchito ya Health Canada kuti athane ndi vuto la zonyansa za azido zomwe zimapezeka mumankhwala ena.

mankhwalaCompanyDINLotiKutha ntchito
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896572005006959April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896572005006960April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896572005006961April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896572005006962April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896572005006963April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896572005011154June 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896572005011156June 2023
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896652005006807April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896652005006808April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896652005006809April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896652005006810April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETS Malingaliro a kampani Mint Pharmaceuticals Inc.023896652105002149December 2022
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896731805012687October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896731805012688October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896731805012689October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896731805012792October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896731905001010December 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS Malingaliro a kampani Mint Pharmaceuticals Inc.023896731905001011December 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896732005006947April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896732005006949April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896732005006950April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896732005006951April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS Malingaliro a kampani Mint Pharmaceuticals Inc.023896732005007297April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896732005007298April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896732005013776August 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMalingaliro a kampani Mint Pharmaceuticals Inc.023896732105002150December 2023
Sangalalani, PDF ndi Imelo

Ponena za wolemba

mkonzi

Mkonzi wamkulu ndi Linda Hohnholz.

Siyani Comment